PDCD1 and pneumonitis: Furthermore, the incidence of pneumonitis varies significantly depending on the type of tumour (higher in NSCLC compared to renal cancer or melanoma), patient risk factors (higher in male smokers with previous lung or autoimmune disease), and the specific type of drug administered (higher for anti-PD-1) (Table 1).